TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

Acknowledging the limitations of murine and primary cell models in predicting clinical outcomes with chimeric antigen receptor (CAR) T cell therapy, researchers created an immunocompetent nonhuman...

Innate lymphoid cells (ILCs) derived from hematopoietic stem cells mitigate graft-versus-host disease (GVHD) in human and mice models but, until now, how they do so has not been fully understood.

Checking for tumor-associated circulating cell-free DNA (TA-cfDNA) after allogeneic stem cell transplantation for acute myelogenous leukemia (AML) could serve as a predictive marker for relapse...

Researchers compared outcomes with different conditioning regimens before allogeneic hematopoietic cell transplantation (allo-HCT) in patients ≥ 50 years with myelodysplastic...

Scientists have developed a model to assess the efficacy of mRNA-based chimeric antigen receptor (CAR) T cells, which are understudied despite their potential in treating glioblastoma (GBM) and...

Innate lymphoid cells (ILCs) derived from hematopoietic stem cells mitigate graft-versus-host disease (GVHD) in human and mice models but, until now, how they do so has not been fully understood.